Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Strategic Expansion into AI-Powered Healthcare Solutions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Akorn AKRXQ

Healthcare Drug Manufacturers - Major
Akorn Inc is a pharmaceutical company. It is engaged in the development, manufacturing, and marketing of generic and prescription pharmaceuticals. The firm has two segments namely Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals including sterile ophthalmics, injectables, and inhalants, and... see more

Recent & Breaking News (OTCPK:AKRXQ)

Akorn, Inc. (AKRX) Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation

Accesswire February 21, 2019

75 Biggest Movers From Yesterday

Benzinga.com  February 21, 2019

Akorn Comments on Fresenius’ Proposed Amended Claims

GlobeNewswire February 20, 2019

AKRX INVESTOR LOSSES ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Akorn, Inc.; Akorn Investors are Encouraged to Contact the Firm – AKRX

GlobeNewswire February 20, 2019

EQUITY ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Akorn, Inc. – AKRX

GlobeNewswire February 15, 2019

Akorn to Report Fourth Quarter and Full Year 2018 Results

GlobeNewswire February 11, 2019

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

GlobeNewswire February 1, 2019

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Tyme Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire January 31, 2019

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akorn, Inc. (AKRX) 

GlobeNewswire January 31, 2019

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire January 30, 2019

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Akorn, Inc. – AKRX

Business Wire January 30, 2019

Akorn, Inc. Investigated by Block & Leviton LLP For Violations of Federal Securities Laws

GlobeNewswire January 30, 2019

Akorn Announces New Executive and Board Appointments

GlobeNewswire January 28, 2019

56 Biggest Movers From Yesterday

Benzinga.com  January 10, 2019

45 Stocks Moving In Wednesday's Mid-Day Session

Benzinga.com  January 9, 2019

Akorn Receives FDA Warning Letter

GlobeNewswire January 9, 2019

Akorn Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire January 8, 2019

Robbins Arroyo LLP: Shareholder Lawsuit Filed Against Officers and Directors of Akorn, Inc. (AKRX)

Business Wire December 21, 2018

The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial

Benzinga.com  December 21, 2018

Akorn Names Douglas S. Boothe as President and CEO

GlobeNewswire December 20, 2018